These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2567971

  • 1. Apomorphine affects cholecystokinin content via preferentially D1 or D2 dopamine receptor according to the regions of the rat brain.
    Yoshikawa T, Fukamauchi F, Shibuya H, Takahashi R.
    Neuropeptides; 1989; 13(2):103-5. PubMed ID: 2567971
    [Abstract] [Full Text] [Related]

  • 2. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ, Marshall JF.
    Behav Brain Res; 1990 May 28; 38(3):233-42. PubMed ID: 1973041
    [Abstract] [Full Text] [Related]

  • 3. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin.
    Liang RZ, Wu M, Yim CC, Mogenson GJ.
    Brain Res; 1991 Jul 19; 554(1-2):85-94. PubMed ID: 1681991
    [Abstract] [Full Text] [Related]

  • 4. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 19; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 5. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 19; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 6. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I, Bryer JB, Starkstein SE, Honig M, Moran TH, Robinson RG.
    Brain Res; 1990 Nov 19; 533(2):286-91. PubMed ID: 1981170
    [Abstract] [Full Text] [Related]

  • 7. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M, Danek L, Smiałowski A.
    Pol J Pharmacol Pharm; 1988 Mar 10; 40(5):535-41. PubMed ID: 2908137
    [Abstract] [Full Text] [Related]

  • 9. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ.
    Pharmacol Biochem Behav; 1988 May 10; 30(1):189-93. PubMed ID: 2902644
    [Abstract] [Full Text] [Related]

  • 10. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 10; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 11. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
    Arnt J, Bøgesø KP, Hyttel J, Meier E.
    Pharmacol Toxicol; 1988 Mar 10; 62(3):121-30. PubMed ID: 3259694
    [Abstract] [Full Text] [Related]

  • 12. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM, Barnes NM, Costall B, Naylor RJ.
    Neuropharmacology; 1990 Apr 10; 29(4):327-36. PubMed ID: 1971430
    [Abstract] [Full Text] [Related]

  • 13. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM, Cereska KS.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr 10; 339(4):383-6. PubMed ID: 2567965
    [Abstract] [Full Text] [Related]

  • 14. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Dec 10; 23(3):1001-10. PubMed ID: 2963970
    [Abstract] [Full Text] [Related]

  • 15. Apomorphine-induced penile erection and yawning: site of action in brain.
    Melis MR, Argiolas A, Gessa GL.
    Brain Res; 1987 Jul 07; 415(1):98-104. PubMed ID: 3497688
    [Abstract] [Full Text] [Related]

  • 16. Cholecystokinin octapeptide potentiates the inhibitory response mediated by D2 dopamine receptors in slices of the ventral tegmental area of the brain in the rat.
    Stittsworth JD, Mueller AL.
    Neuropharmacology; 1990 Feb 07; 29(2):119-27. PubMed ID: 2184375
    [Abstract] [Full Text] [Related]

  • 17. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH, Fechtali T, Rostain JC.
    Neuroscience; 1992 Sep 07; 50(2):395-402. PubMed ID: 1359460
    [Abstract] [Full Text] [Related]

  • 18. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA, Callahan PM, Appel JB.
    Eur J Pharmacol; 1985 Dec 10; 119(1-2):121-5. PubMed ID: 2935415
    [Abstract] [Full Text] [Related]

  • 20. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G, Demenge P.
    J Cardiovasc Pharmacol; 1991 Oct 10; 18(4):548-55. PubMed ID: 1724532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.